Compliance with an infectious disease specialist's advisory consultations on targeted antibiotic usage

Journal of Infection and Chemotherapy

Volumn 11, Issue 2, 2005, Pages 84-88

  Kim, Baek Nam ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Antibiotics; Compliance; Consultation; Drug control; Drug utilization review

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; ASTROMICIN; CARBAPENEM DERIVATIVE; CEFOPERAZONE; CEFPIRAMIDE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; IMIPENEM; ISEPAMICIN; MEROPENEM; MICRONOMICIN; NETILMICIN; TEICOPLANIN; VANCOMYCIN;

ARTICLE; COMPARATIVE STUDY; CONSULTATION; HUMAN; MEDICAL SERVICE; MONITORING; PHYSICIAN ATTITUDE; PRESCRIPTION; PROPHYLAXIS; TIME SERIES ANALYSIS;

EID: 18444403432     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0365-8     Document Type: Article

References (16)

1. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-40.
2. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-99.
3. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resist ant bacteria in hospitals. Infect Dis Clin North Am 1997;11:757-65.
4. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
5. McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478-83.
6. Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991;90:439-44.
7. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157:1689-94.
8. LaRocco A Jr. Concurrent antibiotic review programs - a role for infectious diseases specialists at small community hospitals. Clin Infect Dis 2003;37:742-3.
9. Murray MD, Kohler RB, Main JW. Effect of a targeted antibiotic advisory consult program on hospital antibiotic costs. Hosp Formul 1988;23:518-24, 529-30.
10. Gilbert DN, Moellering RC Jr, Sande MA. The Sanford guide to antimicrobial therapy 2002. 32nd ed. Hyde Park, VT: Antimicrobial therapy; 2002.
11. Anonymous. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 1999;41:75-9.
12. World Health Organization. Guidelines for ATC classification and DDD assignment. 4th ed. Oslo. Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2001.
13. Kang MW, Kim YR. Antibiotic usage in a Korean university hospital. J Korean Soc Chemother 1999;17:264-73.
14. Woo JH. Evaluation of perioperative antimicrobial prophylaxis in Korea. J Korean Soc Chemother 2000;18:156-64.
15. Dunagan WC, Woodward RS, Medoff G, Gray JL, Casabar E, Lawrenz C, et al. Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides. Rev Infect Dis 1991;13:405-12.
16. Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci 1978;275:271-82.